Senior Scientist
Molecular Biology · Ethiopia · 2025-07-07
Framework Evaluation
5 of 3 criteria metThe petitioner completed at least 18 peer reviews and serves on the editorial board of a gene therapy journal.
His innovations in AAV vector platforms are broadly adopted in precision medicine and highly cited.
He authored 6 peer-reviewed articles, including two that rank among the most highly cited in his field.
Evidence was provided showing a high salary relative to others in the field of molecular biology.
He played a pivotal role in his company's technology licensing and AI-enhanced vector discovery.
Why This Petition Was Approved
Evidence
- 6 peer-reviewed journal articles in top-tier journals
- 1,481 citations according to Google Scholar
- At least 18 peer reviews for scientific journals
- Editorial board membership for a reputable gene therapy journal
- Evidence of high salary in relation to peers
- Critical role in a leading biomedical company's AI-enhanced vector discovery initiatives
Similar Cases
Chief Executive Officer (CEO)
Biotechnology · India
Research Scientist
Biotechnology · Pakistan
Principal
Biotechnology · India
Scientist
Biotechnology · India
Frequently Asked Questions
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-07-07.
Browse all casesAt a Glance
EB-1A Case Data
Scraped Case Data
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist